Cc1ccc(-n2cccn2)c([C@@H]2C[C@H]3CN(C)C(=O)[C@]34CCCN24)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?